Page last updated: 2024-10-26

dipyridamole and Hypocapnia

dipyridamole has been researched along with Hypocapnia in 1 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Hypocapnia: Clinical manifestation consisting of a deficiency of carbon dioxide in arterial blood.

Research Excerpts

ExcerptRelevanceReference
"In each of 13 healthy subjects, CBF was measured using (15)O-labeled water and PET at rest and during hypercapnia, hypocapnia, and dipyridamole stress; corresponding CBF values were then compared."3.70Effect of intravenous dipyridamole on cerebral blood flow in humans. A PET study. ( Iida, H; Ito, H; Kinoshita, T; Tamura, Y; Yokoyama, I, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ito, H1
Kinoshita, T1
Tamura, Y1
Yokoyama, I1
Iida, H1

Other Studies

1 other study available for dipyridamole and Hypocapnia

ArticleYear
Effect of intravenous dipyridamole on cerebral blood flow in humans. A PET study.
    Stroke, 1999, Volume: 30, Issue:8

    Topics: Aged; Blood Flow Velocity; Blood Gas Analysis; Blood Pressure; Brain; Cerebrovascular Circulation; D

1999